This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Universitetet I Tromsø—norges Arktiske Universitet. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Marcin Pierechod: Innovator in DNA Binding Proteins
Introduction
Marcin Pierechod is a notable inventor based in Kvaløysletta, Norway. He has made significant contributions to the field of molecular biology, particularly in the development of DNA binding proteins. His innovative work has led to the filing of a patent that showcases his expertise and creativity in this scientific domain.
Latest Patents
Marcin Pierechod holds a patent for a single-strand binding protein. This invention relates to the use of a single-strand DNA binding protein (SSB) that exhibits at least 50% of its maximum ssDNA binding capability in the presence of 500 mM of sodium ions. The SSB is designed to dehybridize a DNA molecule or prevent hybridization of a complementary ssDNA. The patent specifies that the SSB comprises the amino acid sequence of SEQ ID NO:1 or an amino acid sequence that is at least 75% identical to SEQ ID NO:1, or a functional fragment thereof. The invention is particularly useful in solutions containing various ions, enhancing its applicability in biological research.
Career Highlights
Marcin Pierechod is affiliated with the University of Tromsø—The Arctic University of Norway. His role at the university allows him to engage in cutting-edge research and collaborate with other experts in the field. His work has not only contributed to academic knowledge but also has practical implications in biotechnology and genetic research.
Collaborations
Marcin has collaborated with esteemed colleagues such as Nils Peder Willassen and Ulli Rothweiler. These partnerships have fostered a rich environment for innovation and have led to advancements in their shared research interests.
Conclusion
Marcin Pierechod's contributions to the field of DNA binding proteins exemplify the impact of innovative research in molecular biology. His patent reflects a significant advancement that could influence future studies and applications in genetics.